David R. Schleifer

Vendite & Marketing presso Mitralign, Inc.

Health Technology

Consumer Services

Profilo

David R.
Schleifer is currently the Vice President-Marketing at Mitralign, Inc. He previously worked as a Strategic Account Manager at Boston Scientific Corp.
Schleifer holds an MBA from Babson College and an undergraduate degree from Kenyon College.

Posizioni attive di David R. Schleifer

Società	Posizione	Inizio
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Vendite & Marketing	01/02/2016

Tutte le posizioni attive di David R. Schleifer

Precedenti posizioni note di David R. Schleifer

Società	Posizione	Fine
BOSTON SCIENTIFIC CORPORATION	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di David R. Schleifer

Formazione di David R. Schleifer

Kenyon College	Undergraduate Degree
Babson College	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David R. Schleifer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BOSTON SCIENTIFIC CORPORATION	Health Technology

Aziende private	1
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Health Technology